Health Stocks That Can Make You Rich

  Health Stocks That Can Make You Rich Recently, some Health Stocks that combine stability and innovation and that can make you rich have come to the fore.

So how do you find these stocks?

One of the most important ways to find companies that will create wealth in the future is to look carefully at their past. In this case, it is wise to research which companies have been able to adapt to economic conditions and industry changes in their past. We will review one of these companies for you.

Pfizer

Pfizer PFE (NYSE) $38.50 -0.23(-0.59%) is a company that backs its strong resume with clear strategies for the future. Investors looking for the recipe to become a millionaire can find all the features they need in this well-known healthcare company. With a history of 153 years, the pharmaceutical giant has undergone a transformation in recent years. The company, which brought in about 4,000 % between 1980 and 2000, increased only 20 % in the next 20 years. Initially, the company formed a joint venture with GlaxoSmithKline's in the consumer health business in 2019, then split its non-patent and generics division from Upjohn, along with Mylan's assets. This gave rise to Viatris VTRS (NasdaqGS) $15.26 +0.02(+0.13%). CEO Albert Bourla worked and succeeded in making the remains an organization focused on scientific discovery as a singular. The company expanded its partnership with BioNTech and helped build Comirnaty, the first vaccine to use messenger RNA (mRNA). Until last March, Pfizer and BioNTech shipped 430 million doses of the vaccine to 91 countries. Pfizer plans to manufacture up to 3 billion doses by 2022. Bourla aims to make many breakthroughs like Comirnaty in the future. The company's drugs, Prevnar and Eliquis, which prevent blood clots and pneumonia, generated more than $16 billion in revenue last year, along with Ibrance, which is used to treat breast cancer.

Recently, some Health Stocks that combine stability and innovation and that can make you rich have come to the fore.

Stating that they are completely focused on the future despite such success, Bourla stated that the company's new project includes 99 potential treatments for a drug. Management also stressed that it expects drug candidates to be purchased in phase 2 or 3 clinical trials as well. Seeking to be a leader in using mRNA technology to develop new treatments, the company has increased its projected spending on research and development. Pfizer is a worthwhile investment just by looking at its past business. It remains attractive to investors, with an expected $46 million non-Covid-19 income and a 4% dividend yield this year. All in all, Pfizer can be a promising and profitable investment.  

Source: The Motley Fool

 You may also be interested in:

 

Is Apple Stock Worth Investing?